DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS The investigational combination therapy of extended-release pramipexole and extended-release rasagiline controlled symptoms similar to pramipexole alone in this phase 3 trial, but with less sleepiness and orthostatic hypotension. Pramipexole mimics dopamine activity in the brain, and rasagiline increases dopamine levels by blocking dopamine reuptake.
Peer-influenced content. Sources you trust. No registration required. This is HCN.